Experimental and therapeutic medicine最新文献

筛选
英文 中文
[Retracted] Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3 [撤稿】亚甲蓝通过上调lncRNA MEG3缓解骨关节炎的发展
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-05-08 DOI: 10.3892/etm.2024.12562
Xinyi Li, Chaoliang Tang, Jin Wang, Peipei Guo, Chengyao Wang, Yanlin Wang, Zongze Zhang, Huisheng Wu
{"title":"[Retracted] Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3","authors":"Xinyi Li, Chaoliang Tang, Jin Wang, Peipei Guo, Chengyao Wang, Yanlin Wang, Zongze Zhang, Huisheng Wu","doi":"10.3892/etm.2024.12562","DOIUrl":"https://doi.org/10.3892/etm.2024.12562","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140999327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of astaxanthin on particulate matter 2.5‑induced senescence in HaCaT keratinocytes via maintenance of redox homeostasis 虾青素通过维持氧化还原平衡对微粒物质 2.5 诱导的 HaCaT 角质细胞衰老具有保护作用
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-05-08 DOI: 10.3892/etm.2024.12563
Ao Zhen, K. Kang, M. Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Lakmini Herath, J. Hyun
{"title":"Protective effects of astaxanthin on particulate matter 2.5‑induced senescence in HaCaT keratinocytes via maintenance of redox homeostasis","authors":"Ao Zhen, K. Kang, M. Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Lakmini Herath, J. Hyun","doi":"10.3892/etm.2024.12563","DOIUrl":"https://doi.org/10.3892/etm.2024.12563","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140998861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purpurogallin carboxylic acid exhibits synergistic effects with 5‑fluorouracil on liver cancer cells in vitro by targeting ABCG2 Purpurogallin Carxylic acid 与 5-氟尿嘧啶通过靶向 ABCG2 在体外对肝癌细胞产生协同效应
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-05-08 DOI: 10.3892/etm.2024.12564
Pingping Zhao, Wei Liu, Shuqing Wang, Junjie Lun
{"title":"Purpurogallin carboxylic acid exhibits synergistic effects with 5‑fluorouracil on liver cancer cells in vitro by targeting ABCG2","authors":"Pingping Zhao, Wei Liu, Shuqing Wang, Junjie Lun","doi":"10.3892/etm.2024.12564","DOIUrl":"https://doi.org/10.3892/etm.2024.12564","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140999469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osimertinib‑induced erythromelalgia: A case report 奥希替尼诱发的红斑性肢痛症:病例报告
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-05-02 DOI: 10.3892/etm.2024.12561
Anna Bolzon, Alessia Alessia Guidotti, Mauro Alaibac
{"title":"Osimertinib‑induced erythromelalgia: A case report","authors":"Anna Bolzon, Alessia Alessia Guidotti, Mauro Alaibac","doi":"10.3892/etm.2024.12561","DOIUrl":"https://doi.org/10.3892/etm.2024.12561","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141020638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Retracted] Long non‑coding RNA receptor activator of nuclear factor‑κB ligand promotes cisplatin resistance in non‑small cell lung cancer cells [撤稿】长非编码 RNA 核因子-κB 配体受体激活剂促进非小细胞肺癌细胞对顺铂的耐药性
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-05-01 DOI: 10.3892/etm.2024.12560
Zhongcheng Zhu, Xiaoyi Gong, Jing Li, Yufeng Shi, Mingyun Zhang
{"title":"[Retracted] Long non‑coding RNA receptor activator of nuclear factor‑κB ligand promotes cisplatin resistance in non‑small cell lung cancer cells","authors":"Zhongcheng Zhu, Xiaoyi Gong, Jing Li, Yufeng Shi, Mingyun Zhang","doi":"10.3892/etm.2024.12560","DOIUrl":"https://doi.org/10.3892/etm.2024.12560","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141053063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute myocardial infarction due to spontaneous coronary artery dissection in a young male with systemic lupus erythematosus: A case report. 一名患有系统性红斑狼疮的年轻男性因自发性冠状动脉夹层导致急性心肌梗死:病例报告。
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-04-09 DOI: 10.3892/etm.2024.12534
Yunyi Li, Quan Zhou, Xiao Meng
{"title":"Acute myocardial infarction due to spontaneous coronary artery dissection in a young male with systemic lupus erythematosus: A case report.","authors":"Yunyi Li, Quan Zhou, Xiao Meng","doi":"10.3892/etm.2024.12534","DOIUrl":"https://doi.org/10.3892/etm.2024.12534","url":null,"abstract":"Systemic lupus erythematosus (SLE) is an autoimmune disease which typically presents in young women. Patients with SLE exhibit features of accelerated atherosclerosis. Here, the present study reported a rare case of acute myocardial infarction (AMI) in a male patient diagnosed with SLE. A 29-year-old male with no cardiovascular history was diagnosed with AMI and underwent coronary angiography, which showed a long-extended spiral-shaped dissection of the right coronary artery (RCA). The patient's autoimmune panel tested positive for antinuclear, anti-nuclear ribonucleoprotein/Smith and anti-Sjogren's syndrome A antibodies. The patient was diagnosed with SLE and was administered prednisone, hydroxychloroquine and calcium carbonate therapy. At the 3-month follow-up, a repeat coronary angiography showed no dissection in the RCA. Intravascular ultrasound and optical coherence tomography also showed an isolated atherosclerotic lesion without arterial dissection in the RCA. To the best of our knowledge, this is the first reported case of a male patient with SLE who developed myocardial infarction caused by spontaneous coronary artery dissection (SCAD). The present report may provide new insights into possible future treatments for SCAD. SCAD should be considered in patients with SLE and AMI, particularly in young patients without cardiovascular risk factors. Early diagnosis of SCAD is important to provide accurate therapy that differs from the treatment of AMI caused by atherosclerosis.","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140798630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the efficacy of silymarin and dexmedetomidine on kidney and lung tissue in the treatment of sepsis in rats with cecal perforation. 评估水飞蓟素和右美托咪定治疗大鼠盲肠穿孔败血症对肾脏和肺组织的疗效
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-04-03 DOI: 10.3892/etm.2024.12530
Aydin Yavuz, Ayşegül Küçük, Aydan İremnur Ergörün, Ali Doğan Dursun, Zeynep Yiğman, Metin Alkan, Mustafa Arslan
{"title":"Evaluation of the efficacy of silymarin and dexmedetomidine on kidney and lung tissue in the treatment of sepsis in rats with cecal perforation.","authors":"Aydin Yavuz, Ayşegül Küçük, Aydan İremnur Ergörün, Ali Doğan Dursun, Zeynep Yiğman, Metin Alkan, Mustafa Arslan","doi":"10.3892/etm.2024.12530","DOIUrl":"https://doi.org/10.3892/etm.2024.12530","url":null,"abstract":"Sepsis is a systemic inflammatory response syndrome that develops in the host against microorganisms. This response develops away from the primary infection site and results in end-organ damage. The present study aimed to investigate the protective and therapeutic effects on lung and kidney tissue of silymarin (S) and dexmedetomidine (DEX) applied 1 h before and after sepsis induced by the cecal ligation and puncture (CLP) method in rats. A total of 62 rats was randomly divided into eight groups: i) Control (n=6); ii) cecal perforation (CLP; n=8); iii) S + CLP (n=8; S + CLP; S administered 1 h before CPL); iv) CLP + S (n=8; S administered 1 h after CLP); v) DEX + CLP (n=8; D + CLP; DEX administered 1 h before CLP); vi) CLP + D (n=8; DEX administered 1 h after CLP); vii) SD + CLP (n=8; S and DEX administered 1 h before CLP) and viii) CLP + SD (n=8; S and DEX administered 1 h after CLP). After the cecum filled with stool, it was tied with 3/0 silk under the ileocecal valve and the anterior surface of the cecum was punctured twice with an 18-gauge needle. A total of 100 mg/kg silymarin and 100 µg/kg DEX were administered intraperitoneally to the treatment groups. Lung and kidney tissue samples were collected to evaluate biochemical and histopathological parameters. In the histopathological examination, all parameters indicating kidney injury; interstitial edema, peritubular capillary dilatation, vacuolization, ablation of tubular epithelium from the basement membrane, loss of brush border in the proximal tubule epithelium, cell swelling and nuclear defragmentation; were increased in the CLP compared with the control group. Silymarin administration increased kidney damage, including ablation of tubular epithelium from the basement membrane, compared with that in the CLP group. DEX significantly reduced kidney damage compared with the CLP and silymarin groups. The co-administration of DEX + silymarin decreased kidney damage, although it was not as effective as DEX-alone. To conclude, intraperitoneal DEX ameliorated injury in CLP rats. DEX + silymarin partially ameliorated injury but silymarin administration increased damage. As a result, silymarin has a negative effects with this dosage and DEX has a protective effect. In the present study, it was determined that using the two drugs together had a greater therapeutic effect than silymarin and no differences in the effects were not observed any when the application times of the agents were changed.","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140798628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Control of pleural effusion with prednisolone in a patient with yellow nail syndrome: A case report 用泼尼松龙控制黄甲综合征患者的胸腔积液:病例报告
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-03-22 DOI: 10.3892/etm.2024.12512
Manato Taguchi, H. Masuko, Kai Kawashima, Tetsuya Yamagishi, Yuka Kitaoka, R. Shigemasa, Kazufumi Yoshida, Chikako Tsurushige, Hiroaki Satoh, Nobuyuki Hizawa
{"title":"Control of pleural effusion with prednisolone in a patient with yellow nail syndrome: A case report","authors":"Manato Taguchi, H. Masuko, Kai Kawashima, Tetsuya Yamagishi, Yuka Kitaoka, R. Shigemasa, Kazufumi Yoshida, Chikako Tsurushige, Hiroaki Satoh, Nobuyuki Hizawa","doi":"10.3892/etm.2024.12512","DOIUrl":"https://doi.org/10.3892/etm.2024.12512","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140217435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes 基于铁蛋白沉积相关基因的缺血性心肌病分子生物学探索
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-03-22 DOI: 10.3892/etm.2024.12509
Shi-Tao Zhao, Zhi-Cong Qiu, Rui-Yuan Zeng, Hua-Xi Zou, Rong-Bin Qiu, Han-Zhi Peng, Lian-Fen Zhou, Zhi-Qiang Xu, Song-Qing Lai, Li Wan
{"title":"Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes","authors":"Shi-Tao Zhao, Zhi-Cong Qiu, Rui-Yuan Zeng, Hua-Xi Zou, Rong-Bin Qiu, Han-Zhi Peng, Lian-Fen Zhou, Zhi-Qiang Xu, Song-Qing Lai, Li Wan","doi":"10.3892/etm.2024.12509","DOIUrl":"https://doi.org/10.3892/etm.2024.12509","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140213413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent development of oral vaccines (Review) 口服疫苗的最新发展(回顾)
IF 2.7 4区 医学
Experimental and therapeutic medicine Pub Date : 2024-03-22 DOI: 10.3892/etm.2024.12511
Ying Liu, Dominic Man-Kit Lam, Mei Luan, Wenfu Zheng, Hao Ai
{"title":"Recent development of oral vaccines (Review)","authors":"Ying Liu, Dominic Man-Kit Lam, Mei Luan, Wenfu Zheng, Hao Ai","doi":"10.3892/etm.2024.12511","DOIUrl":"https://doi.org/10.3892/etm.2024.12511","url":null,"abstract":"","PeriodicalId":12285,"journal":{"name":"Experimental and therapeutic medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140215667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信